Explore additional resources describing the challenges of therapeutic delivery into solid tumors and TriNav® as a solution.

Pressure-Enabled Conventional TACE for Hepatocellular Carcinoma: A Case Presentation

Read PDF

Improved Tumor Perfusion in Hepatocellular Carcinoma

Watch now

The Use of TriNav to Improve Perfusion in Setting of Iatrogenic Complication

Watch now

Improved Tumor Uptake when Using TriNav® Infusion System in Y-90 Mapping Procedure as Compared to Standard Microcatheter

Read PDF

Precision and Accuracy of the TriNav® Infusion System in Y-90 Mapping and Therapeutic Delivery

Read PDF

PEDD™ DEB-TACE in Patient with HCC

Read PDF

Improved Perfusion with TriNav® Compared to a Conventional Angiographic Catheter in Metastatic Renal Cell Carcinoma

Read PDF

Y90 Mapping Procedure using TriNav® in Patient with Metastatic Neuroendocrine Tumor

Read PDF

Response to Microsphere Embolization Using the TriNav® Infusion System in Hypovascular Leiomyosarcoma Metastases

Read PDF

Right Hepatic Y90 Radiation Segmentectomy using TriNav® in Patient with Hepatocellular Carcinoma

Read PDF

Super-Selective DEB-TACE Performed Using TriNav® in Patient with Hepatocellular Carcinoma

Read PDF

Improved Tumor Uptake when Using a TriNav® Infusion
System in a Y-90 Mapping Procedure

Read PDF

TriNav Improves Y90 Tumor Perfusion in Multicentric, Multilobar HCC

Read PDF

Multi-Center Registry Study of the Safety, Feasibility, and Outcomes of Pressure-Enabled Drug Delivery in DEB-TACE for Patients with HCC

Read PDF

Pressure Enabled Drug Delivery™ — Clinical Evidence. Resonance of multiple clinical studies with different therapeutics

Read PDF

Pressure-Enabled Drug DeliveryTM Improves Tumor Targeting in Liver Radioembolization with Resin Microspheres

Read PDF

The Impact of Pressure-Enabled Drug Delivery on Target Volume Particulate Distribution in Liver-Directed Embolotherapy

Read PDF

A Retrospective Analysis of DEM-TACE Delivered via End-hole Microcatheter vs Pressure-Enabled Drug Delivery in Patients with HCC

Read PDF

Bridging to Transplant with Dr. Jen Berumen and Dr. Isabel Newton

Episode 64

Listen now

Locoregional Therapies for HCC with Dr. Alex Kim

Episode 67

Listen now

Targeting the Tumor Microenvironment with Dr. Terence Gade

Episode 76

Listen now

IO in Private Practice Part I with Dr. Justin Lee

Episode 91

Listen now

IO in Private Practice Part 2 with Dr. Justin Lee

Episode 92

Listen now

January 2019

Cardiovascular and Interventional Radiology

End-hole Versus Microvalve Infusion Catheters in Patients Undergoing Drug-Eluting Microspheres-TACE for Solitary Hepatocellular Carcinoma Tumors: A Retrospective Analysis

Titano et al.

Watch the video for more information.

View now

September 2017

PlOS One

Short-term imaging response after drug-eluting embolic trans-arterial chemoembolization delivered with the Surefire Infusion System® for the treatment of hepatocellular carcinoma

Kim et al.

View now

May 2015

Journal of Vascular and Interventional Radiology

The Impact of an Antireflux Catheter on Target Volume Particulate Distribution in Liver-Directed Embolotherapy: A Pilot Study

Pasciak et al.

View now

April 2018

Journal of Vascular and Interventional Radiology

Abstract No. 133 Surefire Infusion System (SIS) hepatocellular carcinoma registry study interim results: a multicenter study of the safety, feasibility, and outcomes of the SIS expandable-tip microcatheter in DEB-TACE

Kapoor et al.

View now

Let us tell you more.

Contact us to learn more about this improved technology for the proprietary PEDD method.

References

1. TriSalus TriNav® Infusion System, Instructions for Use.